文献速递皮肤肿瘤

不同临床医生进行皮肤活检的需活检数比较

Number of skin biopsies needed per malignancy: Comparing the use of skin biopsies among dermatologists and nondermatologist clinicians.
PubMed 文献 · J Am Acad Dermatol · 2019-08-10

本研究比较了皮肤科医生、皮肤科高级实践专业人员、初级保健医生和其他非皮肤科临床医生的皮肤活检使用情况。结果显示,皮肤科医生的需活检数(NNB)最低(2.82),初级保健医生(4.55)与皮肤科高级实践专业人员(4.69)相似,其他非皮肤科临床医生最高(6.55)(P < .001)。

要点

  • 皮肤科医生的NNB为2.82,显著低于其他临床医生组。
  • 初级保健医生的NNB为4.55,与皮肤科高级实践专业人员(4.69)相似。
  • 非黑色素瘤皮肤癌的NNB组间差异显著,而黑色素瘤的NNB组间差异不显著。

核心结论

  • 皮肤科医生的需活检数(NNB)在所有临床医生组中最低。
  • 初级保健医生的NNB与皮肤科高级实践专业人员相似。

研究设计与样本

  • 回顾性研究,纳入研究期间提交至某机构的皮肤活检的病理报告、申请单和临床记录。
  • 排除用于炎症性疾病、美容或功能目的以及再切除的皮肤活检。
  • NNB计算为活检病变数除以组织学证实的皮肤癌数。

主要发现

  • 总体NNB:皮肤科医生2.82,高级实践专业人员4.69,初级保健医生4.55,其他非皮肤科临床医生6.55(P < .001)。
  • 非黑色素瘤皮肤癌NNB:皮肤科医生2.00,高级实践专业人员2.71,初级保健医生2.36,其他非皮肤科临床医生3.47(P < .001)。
  • 黑色素瘤NNB:皮肤科医生14.33,高级实践专业人员20.78,初级保健医生27.80,其他非皮肤科临床医生53.56(P = .061)。

临床怎么用

  • 皮肤科医生应继续承担皮肤癌筛查的主要责任,因其NNB最低。
  • 初级保健医生和皮肤科高级实践专业人员的活检效率相似,可考虑在筛查中发挥更大作用。

局限性

  • NNB仅反映活检使用情况,无法提供未活检恶性病变数量的信息。
  • 皮肤癌患病率在皮肤科和非皮肤科实践中存在差异。
  • 结果不能推广至所有实践环境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are too few board-certified dermatologists to treat all patients with skin disease. Primary care physicians often serve at the frontline of skin cancer screening. OBJECTIVE: To compare biopsy use among dermatologist physicians, dermatology advanced practice professionals (APPs), primary care physicians (PCPs), and other nondermatology clinicians. METHODS: Pathology reports, requisition forms, and clinical notes of skin biopsies submitted to our institution during the study period were reviewed. Skin biopsies for inflammatory conditions, cosmetic or functional purposes, and re-excisions were excluded. The number needed to biopsy (NNB) was calculated as the number of biopsied lesions divided by histologically proven skin cancers. RESULTS: The NNB by clinician type was 2.82 for dermatology physicians, 4.69 for APPs, 4.55 for nondermatology PCPs, and 6.55 for other nondermatology clinicians (P < .001). The NNB was significant between clinician groups for nonmelanoma skin cancer (dermatology physicians, 2.00; APPs, 2.71; PCPs, 2.36; and other nondermatology clinicians, 3.47; P < .001) but not for melanoma (dermatology clinicians, 14.33; APPs, 20.78; PCPs, 27.80; and other nondermatology clinicians, 53.56; P = .061). LIMITATIONS: The NNB represents a measure of use but gives no insight into the number of malignant lesions that go unbiopsied and, therefore, undiagnosed. The prevalence of skin cancer varies among dermatology and nondermatology practices. The results are not generalizable to all practice settings. CONCLUSIONS: Dermatology physicians had the lowest NNB of all clinician groups. PCPs performed similarly to dermatology APPs.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Privalle A, Havighurst T, Kim K, et al. Number of skin biopsies needed per malignancy: Comparing the use of skin biopsies among dermatologists and nondermatologist clinicians. J Am Acad Dermatol. 2019. PMID: 31408683. doi:10.1016/j.jaad.2019.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。